New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
aTyr Pharma, Inc. (ATYR) vs NKGen Biotech, Inc. (NKGN)
- aTyr Pharma, Inc. ATYR 3.82 +3.52%
- NKGen Biotech, Inc. NKGN 0.00 NaN
aTyr Pharma, Inc. and NKGen Biotech, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and NKGen Biotech, Inc. are of similar size ($9.0M and $8.8M). Across the 8 metrics below, aTyr Pharma, Inc. leads on 4 and NKGen Biotech, Inc. on 4.
Valuation
Profitability
| Metric | ATYR | NKGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (152.19%) | — | 0.00% |
| Net margin | (155.18%) | — | 0.00% |
| Free cash flow margin | (148.11%) | — | 0.00% |
| Return on equity | (93.69%) | 44.70% | (51.58%) |
| Return on assets | (64.07%) | (146.49%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack